All SLAMF7/CD319 reagents are produced in house and quality controlled, including 8 SLAMF7/CD319 Antibody, 27 SLAMF7/CD319 Gene, 2 SLAMF7/CD319 Lysate, 2 SLAMF7/CD319 Protein, 2 SLAMF7/CD319 qPCR. All SLAMF7/CD319 reagents are ready to use.
Recombinant SLAMF7/CD319 proteins are expressed by HEK293 Cells with fusion tags as C-His.
SLAMF7/CD319antibodies are validated with different applications, which are ELISA, FCM, WB.
SLAMF7/CD319cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each SLAMF7/CD319 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
SLAM family member 7 (SLAMF7), also known as CRACC, CD319, CD2-like receptor-activating cytotoxic cells, and CS1, is a single-pass type I membrane protein and a member of the CD2 family of cell surface receptors. SLAMF7 is expressed in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-cell lines, or T-cell lines. Although the cytoplasmic domain of CS1 contains immunoreceptor tyrosine-based switch motifs (ITSM), which enables to recruite signaling lymphocyte activation molecule (SLAM)-associated protein (SAP/SH2D1A), it activates NK cells in the absence of a functional SAP. CS1 is a self ligand and homophilic interaction of CS1 regulates NK cell cytolytic activity. CRACC positively regulated natural killer cell functions by a mechanism dependent on the adaptor EAT-2 but not the related adaptor SAP. However, in the absence of EAT-2, CRACC potently inhibited natural killer cell function. It was also inhibitory in T cells, which are typically devoid of EAT-2. Thus, CRACC can exert activating or inhibitory influences on cells of the immune system depending on cellular context and the availability of effector proteins.